I

Integrum AB
STO:INTEG B

Watchlist Manager
Integrum AB
STO:INTEG B
Watchlist
Price: 9.61 SEK 1.48% Market Closed
Market Cap: kr250.1m

Relative Value

The Relative Value of one INTEG B stock under the Base Case scenario is hidden SEK. Compared to the current market price of 9.61 SEK, Integrum AB is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

INTEG B Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Multiples Across Competitors

INTEG B Competitors Multiples
Integrum AB Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
SE
Integrum AB
STO:INTEG B
250.1m SEK 2.6 -8.4 -5.4 -5.4
US
Abbott Laboratories
NYSE:ABT
191.3B USD 4.3 29 16.5 22.4
US
Intuitive Surgical Inc
NASDAQ:ISRG
172.7B USD 17 59.9 45.6 55.2
US
Stryker Corp
NYSE:SYK
139.6B USD 5.5 42.8 21.7 26.3
IE
Medtronic PLC
NYSE:MDT
133.7B USD 3.8 27.9 15.6 22.6
US
Boston Scientific Corp
NYSE:BSX
115.8B USD 6 41.5 24.6 33.5
US
Becton Dickinson and Co
NYSE:BDX
59B USD 2.7 35.1 12.8 21.8
DE
Siemens Healthineers AG
XETRA:SHL
46.4B EUR 2 22 12.5 17.6
US
IDEXX Laboratories Inc
NASDAQ:IDXX
51.8B USD 12 48.8 34.9 38.5
US
Edwards Lifesciences Corp
NYSE:EW
45.7B USD 7.7 33 23.4 25.7
US
Resmed Inc
NYSE:RMD
39B USD 7.2 26.2 18.5 20.6
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
SE
I
Integrum AB
STO:INTEG B
Average EV/EBITDA: 22.6
Negative Multiple: -5.4
N/A N/A
US
Abbott Laboratories
NYSE:ABT
16.5
9%
1.8
US
Intuitive Surgical Inc
NASDAQ:ISRG
45.6
24%
1.9
US
Stryker Corp
NYSE:SYK
21.7
12%
1.8
IE
Medtronic PLC
NYSE:MDT
15.6
8%
2
US
Boston Scientific Corp
NYSE:BSX
24.6
22%
1.1
US
Becton Dickinson and Co
NYSE:BDX
12.8
8%
1.6
DE
Siemens Healthineers AG
XETRA:SHL
12.5
11%
1.1
US
IDEXX Laboratories Inc
NASDAQ:IDXX
34.9
11%
3.2
US
Edwards Lifesciences Corp
NYSE:EW
23.4
13%
1.8
US
Resmed Inc
NYSE:RMD
18.5
11%
1.7
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
SE
I
Integrum AB
STO:INTEG B
Average EV/EBIT: 28.4
Negative Multiple: -5.4
N/A N/A
US
Abbott Laboratories
NYSE:ABT
22.4
17%
1.3
US
Intuitive Surgical Inc
NASDAQ:ISRG
55.2
25%
2.2
US
Stryker Corp
NYSE:SYK
26.3
16%
1.6
IE
Medtronic PLC
NYSE:MDT
22.6
17%
1.3
US
Boston Scientific Corp
NYSE:BSX
33.5
32%
1
US
Becton Dickinson and Co
NYSE:BDX
21.8
21%
1
DE
Siemens Healthineers AG
XETRA:SHL
17.6
15%
1.2
US
IDEXX Laboratories Inc
NASDAQ:IDXX
38.5
11%
3.5
US
Edwards Lifesciences Corp
NYSE:EW
25.7
14%
1.8
US
Resmed Inc
NYSE:RMD
20.6
12%
1.7